Oral formulations for anti-tumor compounds

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S451000, C424S464000, C424S489000, C514S280000

Reexamination Certificate

active

10110225

ABSTRACT:
The present invention relates to a semi-solid filling medium which comprises a camptothecin derivative; a pharmaceutically acceptable carrier matrix which is a polyglycolized glyceride; and an effective thickening-reducing and stabilizing-promoting amount of one or more pharmaceutically acceptable excipients.

REFERENCES:
patent: 5433951 (1995-07-01), Serajuddin et al.
patent: 5552156 (1996-09-01), Burke
patent: 5741524 (1998-04-01), Staniforth et al.
patent: 5908835 (1999-06-01), Bissery
patent: 5954998 (1999-09-01), Zhou et al.
patent: 6201014 (2001-03-01), Gardiner
patent: 6248771 (2001-06-01), Shenoy et al.
patent: 6531139 (2003-03-01), Gao et al.
patent: 6569452 (2003-05-01), Civaroli et al.
patent: 6573290 (2003-06-01), Love
patent: 96 11669 (1996-04-01), None
patent: 99 06031 (1999-02-01), None
patent: 99 42086 (1999-08-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Oral formulations for anti-tumor compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral formulations for anti-tumor compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral formulations for anti-tumor compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3762740

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.